Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Beta-blockers in anxiety disorders
Peggy E. Hayes, S. Charles Schulz
Research output
:
Contribution to journal
›
Article
›
peer-review
56
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Beta-blockers in anxiety disorders'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anti-anxiety
33%
Anxiety Disorders
100%
Benzodiazepines
33%
Beta-blockers
100%
Blocking Agent
33%
Conventional Treatment
33%
Depressive Illness
33%
Drug Regimen
33%
Generalized Anxiety Disorder
33%
Non-responders
33%
Palpation
33%
Panic
33%
Panic Disorder
66%
Physical Symptoms
33%
Propranolol
100%
Somatic Complaints
33%
Symptom Relief
33%
Tachycardia
33%
Medicine and Dentistry
Anxiety Disorder
100%
Benzodiazepine Derivative
33%
Beta Adrenergic Receptor Blocking Agent
100%
Blocking Agent
33%
Cardiovascular System
33%
Depressive Disorder
33%
Generalized Anxiety Disorder
33%
Palpitations
33%
Panic Disorder
66%
Propranolol
100%
Somatics
33%
Tachyarrhythmia
33%
Nursing and Health Professions
Anxiety Disorder
100%
Benzodiazepine Derivative
33%
Beta Adrenergic Receptor Blocking Agent
100%
Blocking Agent
33%
Depressive Disorder
33%
Generalized Anxiety Disorder
33%
Heart Palpitation
33%
Propranolol
100%
Tachycardia
33%
Neuroscience
Anxiety Disorder
100%
Beta Blocker
100%
Depressive Disorder
33%
Generalized Anxiety Disorder
33%
Panic Disorder
66%
Propranolol
100%
Somatics
33%
Pharmacology, Toxicology and Pharmaceutical Science
Anxiety Disorder
100%
Beta Adrenergic Receptor Blocking Agent
100%
Blocking Agent
33%
Depressive Disorder
33%
Generalized Anxiety Disorder
33%
Heart Palpitation
33%
Propranolol
100%
Tachycardia
33%